Evidence map›Paper›PMID 27920318›Full record

ArticleHealth affairs (Project Hope)2016

Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Colleen M Grogan, Christina Andrews, Amanda Abraham, Keith Humphreys, Harold A Pollack, Bikki Tran Smith, Peter D Friedmann

Open access · greenAbstract read
In one paragraph

Article in Health affairs (Project Hope), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 2 countries.

Colleen M GroganColleen M. Grogan (cgrogan@uchicago.edu) is a professor at the School of Social Service Administration, University of Chicago, in Illinois.
Christina AndrewsChristina Andrews is an assistant professor at the College of Social Work, University of South Carolina, in Columbia.
Amanda AbrahamAmanda Abraham is an assistant professor in the Department of Public Administration and Policy at the University of Georgia, in Athens.
Keith HumphreysKeith Humphreys is a professor of psychiatry and behavioral sciences in the Department of Psychiatry at the Stanford School of Medicine, in California.
Harold A PollackHarold A. Pollack is the Helen Ross Professor at the School of Social Service Administration, University of Chicago.
Bikki Tran SmithBikki Tran Smith is a doctoral student at the School of Social Service Administration, University of Chicago.
Peter D FriedmannPeter D. Friedmann is chief research officer at Baystate Health, in Springfield, Massachusetts.
Baystate Health · USRoss School · USSmith Institute · GBStanford Medicine · USUniversity of Georgia · USUniversity of Illinois Chicago · USUniversity of South Carolina · US

Funding

Impact of health reform on outpatient substance abuse treatment programsR01DA034634 · NIDA · RHODE ISLAND HOSPITAL · PI FRIEDMANN, PETER D · 2013 to 2017
$4.0M
NIDA NIH HHS R01 DA034634
6 · The paper itself

Abstract

The Affordable Care Act requires state Medicaid programs to cover substance use disorder treatment for their Medicaid expansion population but allows states to decide which individual services are reimbursable. To examine how states have defined substance use disorder benefit packages, we used data from 2013-14 that we collected as part of an ongoing nationwide survey of state Medicaid programs. Our findings highlight important state-level differences in coverage for substance use disorder treatment and opioid use disorder medications across the United States. Many states did not cover all levels of care required for effective substance use disorder treatment or medications required for effective opioid use disorder treatment as defined by American Society of Addiction Medicine criteria, which could result in lack of access to needed services for low-income populations.

Indexed as

Analgesics, OpioidHealth Services AccessibilityHumansInsurance CoverageMedicaidOpioid-Related DisordersPatient Protection and Affordable Care ActSurveys and QuestionnairesUnited StatesAnalgesics, OpioidAccess To CareDisparitiesHealth ReformMedicaidMental Health/Substance Abuse

Identifiers

PMID27920318
PMCPMC5304419
OpenAlexW2560486877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.